Our | Products


GEFIT





THERAPEUTIC AREA: Oncology
ACTIVE PRINCIPLE: Gefitinib
PRESENTATION: 250 mg x 30 coated tablets
INDICATION:

  • non-small cell lung cancer

COUNTRIES WHERE IT IS MARKETED:
Argentina